| 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on … RA Nishimura, CM Otto, RO Bonow, BA Carabello, JP Erwin III, ... Circulation 129 (23), e521-e643, 2014 | 9588* | 2014 |
| Intensive lipid lowering with atorvastatin in patients with stable coronary disease JC LaRosa, SM Grundy, DD Waters, C Shear, P Barter, JC Fruchart, ... New England Journal of Medicine 352 (14), 1425-1435, 2005 | 4956 | 2005 |
| Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials CT Trialists The Lancet 376 (9753), 1670-1681, 2010 | 4356* | 2010 |
| Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial FIELD Study Investigators The Lancet 366 (9500), 1849-1861, 2005 | 4203 | 2005 |
| Effects of torcetrapib in patients at high risk for coronary events PJ Barter, M Caulfield, M Eriksson, SM Grundy, JJP Kastelein, M Komajda, ... New England journal of medicine 357 (21), 2109-2122, 2007 | 3747 | 2007 |
| New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk J Dupuis, C Langenberg, I Prokopenko, R Saxena, N Soranzo, ... Nature genetics 42 (2), 105-116, 2010 | 2549 | 2010 |
| Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group New England Journal of Medicine 339 (19), 1349-1357, 1998 | 2489 | 1998 |
| Effects of dalcetrapib in patients with a recent acute coronary syndrome GG Schwartz, AG Olsson, M Abt, CM Ballantyne, PJ Barter, J Brumm, ... New England Journal of Medicine 367 (22), 2089-2099, 2012 | 2288 | 2012 |
| Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR Trial) PH Jones, MH Davidson, EA Stein, HE Bays, JM McKenney, E Miller, ... The American journal of cardiology 92 (2), 152-160, 2003 | 2201 | 2003 |
| HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events P Barter, AM Gotto, JC LaRosa, J Maroni, M Szarek, SM Grundy, ... New England journal of medicine 357 (13), 1301-1310, 2007 | 2134 | 2007 |
| Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis D Preiss, SRK Seshasai, P Welsh, SA Murphy, JE Ho, DD Waters, ... Jama 305 (24), 2556-2564, 2011 | 1901 | 2011 |
| Antiinflammatory properties of HDL PJ Barter, S Nicholls, KA Rye, GM Anantharamaiah, M Navab, ... Circulation research 95 (8), 764-772, 2004 | 1708 | 2004 |
| Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity R Ross, IJ Neeland, S Yamashita, I Shai, J Seidell, P Magni, RD Santos, ... Nature Reviews Endocrinology 16 (3), 177-189, 2020 | 1363 | 2020 |
| Effect of two intensive statin regimens on progression of coronary disease SJ Nicholls, CM Ballantyne, PJ Barter, MJ Chapman, RM Erbel, P Libby, ... New England Journal of Medicine 365 (22), 2078-2087, 2011 | 1125 | 2011 |
| Cholesteryl ester transfer protein: a novel target for raising HDL and inhibiting atherosclerosis PJ Barter, HB Brewer Jr, MJ Chapman, CH Hennekens, DJ Rader, ... Arteriosclerosis, thrombosis, and vascular biology 23 (2), 160-167, 2003 | 1122 | 2003 |
| High-density lipoproteins inhibit cytokine-induced expression of endothelial cell adhesion molecules GW Cockerill, KA Rye, JR Gamble, MA Vadas, PJ Barter Arteriosclerosis, thrombosis, and vascular biology 15 (11), 1987-1994, 1995 | 1093 | 1995 |
| A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs ND Yeomans, Z Tulassay, L Juhász, I Rácz, JM Howard, ... New England Journal of Medicine 338 (11), 719-726, 1998 | 1060 | 1998 |
| International Day for the Evaluation of Abdominal Obesity (IDEA) a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168 000 primary care patients … B Balkau, JE Deanfield, JP Després, JP Bassand, KAA Fox, SC Smith Jr, ... Circulation 116 (17), 1942-1951, 2007 | 1046 | 2007 |
| Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement IJ Neeland, R Ross, JP Després, Y Matsuzawa, S Yamashita, I Shai, ... The lancet Diabetes & endocrinology 7 (9), 715-725, 2019 | 920 | 2019 |
| Safety of anacetrapib in patients with or at high risk for coronary heart disease CP Cannon, S Shah, HM Dansky, M Davidson, EA Brinton, AM Gotto Jr, ... New England Journal of Medicine 363 (25), 2406-2415, 2010 | 817 | 2010 |
